This contract expires in 83 days (Sep 29, 2026).
PHLOW CORP. - US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.
Key Details
Description
US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.
Context & Analysis
On Oct 23, 2025, Department of Health and Human Services obligated $591,391,544.88 to PHLOW CORP. for us based advanced api manufacturing. base period funding for us based advanced manufacturing of covid-19 essential medicines and future threats.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a cost plus fixed fee contract. Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in RICHMOND, VA. The contract is scheduled through Sep 29, 2026 — approximately 3 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325412 — related awards are listed below.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.